Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
HILLSIDE, NJ / ACCESS Newswire / November 10, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its...
Pharmaceutical
Federal Marijuana Crackdown Confirms the Future: DEA’s Obstruction of MMJ Science Exposed as Congress Moves to Re-Criminalize the $30 Billion THC Gray Market
MMJ International Holdings stands as one of a few compliant, FDA regulated blueprint for cannabis medicine as a 37 state...
The National Children’s Cancer Society Awards 50 Scholarships to Childhood Cancer Survivors Nationwide
For recipients across the country, this scholarship eases the financial burden of college while instilling hope, optimism, and confidence in...
TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives
TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry...
Rebuilding the Tumor Microenvironment for In Vitro Discovery, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees...
Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks
NAPERVILLE, IL / ACCESS Newswire / November 10, 2025 / Brain Balance, a leading brain health and development program that...
Medical Care Technologies Inc. (OTC PINK:MDCE) Marches Forward with Breakthrough Patent-Pending AI Healthcare Solutions using Smart Devices
A very unique multi-vertical health AI engine capable of early detection for mental health, wound infection, skin cancer, and disease...
US Med-Equip Named a Top Workplace for the Seventh Consecutive Year
Company recognized for its people-first culture and mission-driven growth serving hospitals nationwide HOUSTON, TEXAS / ACCESS Newswire / November 10,...
Avante Health Solutions Partners with Industry Leader Chronos Imaging LLC
Chronos Imaging develops the new MRC 200 0407 ROT-GS 1004 and MRC 200 0508 ROT GS 1003 replacement tubes, distributed...
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it...
Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors
First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting SEATTLE, WASHINGTON /...
LEM Surgical Achieves Major US Clinical Milestone With Dynamis Robotic Surgical System
BERN, CH / ACCESS Newswire / November 10, 2025 / LEM Surgical, a leading innovator in hard tissue surgical robotics,...
Olympia Pharmaceuticals Launches OlympiaGO: A Convenient Hydration Drink Mix for Immune Support and Wellness
New product line offers three refreshing flavors designed to boost hydration, energy, and immunity, all while supporting a healthy lifestyle...
Codexis Announces Signing of Lease for GMP Manufacturing Facility
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for...
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
PONTE VEDRA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics...
Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis
Rosnilimab was safe and well tolerated with similar adverse event rates vs. placeboObserved expected pharmacology, including ~90% depletion of pathogenic...
Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company’s R&D Pipeline
Initial Investment of $1 Million Received from Hexstone Capital LLC Upon ClosingMELBOURNE, Australia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Propanc...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025
Financials for Second Quarter of Fiscal Year 2026 Ended September 30, 2025 will be released on Friday, November 14, 2025Northvale,...
Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
The world's largest tech and AI show brought groundbreaking innovations in healthcare, neurotech and life sciences to the forefront M42,...